These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34957797)

  • 1. Relationship between Lipoprotein(a) and cardiovascular risk factors-data from 4602 participants of the ELITE study.
    Schrader B; Shakoor A; Schmidt A; Schrader J; Vaske B; Haller H; Koziolek M; Elsässer A; Lüders S
    Rev Cardiovasc Med; 2021 Dec; 22(4):1569-1575. PubMed ID: 34957797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a), cardiovascular disease, and contemporary management.
    Jacobson TA
    Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the Linear Association Between Blood Pressure Levels and Cardiovascular Diseases in the Absence of Major Risk Factors in China.
    Zheng R; Xu Y; Li M; Lu J; Wu S; Niu J; Zhao Z; Chen L; Huo Y; Xu M; Wang T; Wang S; Lin H; Qin G; Yan L; Wan Q; Chen L; Shi L; Hu R; Tang X; Su Q; Yu X; Qin Y; Chen G; Gao Z; Wang G; Shen F; Luo Z; Chen Y; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Li Q; Mu Y; Zhao J; Wang W; Ning G; Bi Y;
    Circ Cardiovasc Qual Outcomes; 2022 Sep; 15(9):e008774. PubMed ID: 36065814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).
    Afshar M; Pilote L; Dufresne L; Engert JC; Thanassoulis G
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27108248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment.
    Stiekema LCA; Stroes ESG; Verweij SL; Kassahun H; Chen L; Wasserman SM; Sabatine MS; Mani V; Fayad ZA
    Eur Heart J; 2019 Sep; 40(33):2775-2781. PubMed ID: 30561610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study.
    Madsen CM; Kamstrup PR; Langsted A; Varbo A; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):255-266. PubMed ID: 31578080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic Experience.
    Anastasiou G; Sakka E; Blathra E; Kalivi A; Elisaf M; Liamis G; Liberopoulos E
    Arch Med Res; 2021 May; 52(4):397-404. PubMed ID: 33380360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?
    Schettler VJJ; Ringel J; Jacob S; Julius U; Klingel R; Heigl F; Roeseler E; Grützmacher P;
    Atheroscler Suppl; 2017 Nov; 30():44-49. PubMed ID: 29096860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.
    Koschinsky ML; Bajaj A; Boffa MB; Dixon DL; Ferdinand KC; Gidding SS; Gill EA; Jacobson TA; Michos ED; Safarova MS; Soffer DE; Taub PR; Wilkinson MJ; Wilson DP; Ballantyne CM
    J Clin Lipidol; 2024; 18(3):e308-e319. PubMed ID: 38565461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; García-Ruiz JM; Mendiguren J; Bueno H; Pocock S; Ibáñez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2017 Dec; 70(24):2979-2991. PubMed ID: 29241485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions.
    Welsh P; Welsh C; Celis-Morales CA; Brown R; Ho FK; Ferguson LD; Mark PB; Lewsey J; Gray SR; Lyall DM; Gill JMR; Pell JP; de Lemos JA; Willeit P; Sattar N
    Eur J Prev Cardiol; 2022 Feb; 28(18):1991-2000. PubMed ID: 33624048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actual situation of lipoprotein apheresis in patients with elevated lipoprotein(a) levels.
    Julius U; Tselmin S; Schatz U; Fischer S; Birkenfeld AL; Bornstein SR
    Atheroscler Suppl; 2019 Dec; 40():1-7. PubMed ID: 31818437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes.
    Berk KA; Yahya R; Verhoeven AJM; Touw J; Leijten FP; van Rossum EF; Wester VL; Lips MA; Pijl H; Timman R; Erhart G; Kronenberg F; Roeters van Lennep JE; Sijbrands EJG; Mulder MT
    Diabetologia; 2017 Jun; 60(6):989-997. PubMed ID: 28386638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    Nissen SE; Wolski K; Balog C; Swerdlow DI; Scrimgeour AC; Rambaran C; Wilson RJ; Boyce M; Ray KK; Cho L; Watts GF; Koren M; Turner T; Stroes ES; Melgaard C; Campion GV
    JAMA; 2022 May; 327(17):1679-1687. PubMed ID: 35368052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid Clinic.
    Schatz U; Fischer S; Müller G; Tselmin S; Birkenfeld AL; Julius U; März W; Bornstein SR
    Atheroscler Suppl; 2019 Dec; 40():94-99. PubMed ID: 31818455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein apheresis for lipoprotein(a) and cardiovascular disease.
    Moriarty PM; Gray JV; Gorby LK
    J Clin Lipidol; 2019; 13(6):894-900. PubMed ID: 31753721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical management of dyslipidemia with elevated lipoprotein(a).
    Riche DM; East HE; Priest HM
    J Am Pharm Assoc (2003); 2008; 48(6):803-7. PubMed ID: 19019811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.